Insight
Nina Niu Sanford: First clinical PULSAR study is out
Nina Niu Sanford/utswmed.org

Nina Niu Sanford: First clinical PULSAR study is out

Nina Niu Sanford, Chief of Gastrointestinal Radiation Oncology at Harvard/Brigham and Women’s Hospital/Massachusetts General Hospital, shared a post on X about a recent paper by Michael Dohopolski et al. published in International Journal of Radiation Oncology, Biology, Physics:

“First clinical PULSAR study is out! Congrats Michael Dohopolski, Tu Dan, Bob Timmerman and rest of UTSW CNS team!”

“Exploratory Evaluation of Personalized Ultra-Fractionated Stereotactic Adaptive Radiotherapy (PULSAR) with CNS-Active Drugs in Brain Metastases Treatment”

Authors: Michael Dohopolski, Luiza Schmitt, Soummitra Anand, Tu Dan, Zabi Wardak, et al.

More posts featuring Nina Sanford.

Nina Niu Sanford is an Assistant Professor and Chief of Gastrointestinal Radiation Oncology at Harvard/Brigham and Women’s Hospital/Massachusetts General Hospital. She specializes in treating gastrointestinal cancers and actively participates in clinical trials combining high-dose radiation therapy with immunotherapy. Additionally, she researches healthcare access disparities and conducts pan-cancer outcomes research using large databases.

Bob Timmerman cancer clinical trials Luiza Schmitt Michael Dohopolski Nina Niu Sanford OncoDaily Oncology PULSAR Soummitra Anand Tu Dan UTSW Zabi Wardak